Lineage Cell Therapeutics (LCTX) Stock Price
$1.38 2.2%
to add to portfolio
AI Score
-
Alternative
9 -
Fundamental
2 -
Technical
7
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Lineage Cell Therapeutics, AI stock picks, stock alerts and much more.
LCTX AI Stock Analysis
AI stock analysis for LCTX is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Lineage Cell Therapeutics (LCTX) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Lineage Cell Therapeutics (LCTX) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Lineage Cell Therapeutics (LCTX), currently trading at $1.38, will... Sign up to access price prediction.
About LCTX
-
Lineage Cell Therapeutics, Inc.
-
Symbol
LCTX
-
Market
AMEX
-
Industry
Biotechnology
-
Market Cap
315.1M
Similar Stocks
 |
Cybin CYBN |
$6.04 0.5% |
4 |
 |
Calidi Biotherapeutics CLDI |
$1.6 0.00% |
4 |
 |
NovaBay Pharmaceuticals NBY |
$2.19 20.1% |
4 |
News
LCTX Alternative Data
Web Traffic
Lineage Cell Therapeutics receives an estimated 9376 monthly visitors to lineagecell.com.
-
Web Traffic
9376
-
Change from Previous Month
14.4%
-
3 Month Change
88.7%
-
YoY Change
88.7%
Twitter Followers
Lineage Cell Therapeutics has 2,322 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.7% over the last month.
-
Twitter Followers
2322
-
Daily Change
0%
-
1 Month Change
0.7%
-
3 Month Change
3.2%
-
YoY Change
3.2%
Facebook Engagement
Lineage Cell Therapeutics has engaged 14 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
14
-
Daily Change
12.5%
-
1 Month Change
16.7%
-
3 Month Change
7.7%
-
YoY Change
7.7%
LinkedIn Followers
6,027 are following Lineage Cell Therapeutics on LinkedIn, up by 1.6% over the last month.
-
LinkedIn Followers
6027
-
Daily Change
0%
-
1 Month Change
1.6%
-
3 Month Change
5.3%
-
YoY Change
5.3%
Job Postings
Lineage Cell Therapeutics currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Employees
According to LinkedIn, Lineage Cell Therapeutics has 32 employees, up by 3.2% over the last month.
-
LinkedIn Employees
32
-
Daily Change
0%
-
1 Month Change
3.2%
-
3 Month Change
5.9%
-
YoY Change
5.9%
Reddit Mentions
Lineage Cell Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
News Mentions
Lineage Cell Therapeutics was mentioned 2 times in the news yesterday.
-
News Mentions
2
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
LCTX Financials
LCTX Key Metrics
-
Total Revenue
$2.9M
-
Net Income
-$3.3M
-
Earnings per Share
-$0.0163
-
Free cash flow
-$6.7M
-
EBITDA
-$5M
-
EBITDA Ratio
-1.72908
-
Total Assets
$113.2M
LCTX 2-year Revenue & Income
LCTX 2-year Free Cash Flow
LCTX Technicals
LCTX SMA
LCTX RSI
FAQ
What's the current price of Lineage Cell Therapeutics (LCTX) Stock?
The price of an Lineage Cell Therapeutics (LCTX) share is $1.38.
What's the market cap of Lineage Cell Therapeutics?
The current market cap of Lineage Cell Therapeutics is 315.1M.
What are some stocks similar to Lineage Cell Therapeutics (LCTX) that investors often compare it to?
Lineage Cell Therapeutics (LCTX) is often compared to similar stocks such as Cybin, Calidi Biotherapeutics and NovaBay Pharmaceuticals.
What is the forecast for Lineage Cell Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Lineage Cell Therapeutics' stock price to be around $1.48 in 2026. Starting from the current price of $1.38, this represents a 7% change in price, indicating a bullish outlook for the stock.
How to buy Lineage Cell Therapeutics (LCTX) Stock?
Lineage Cell Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Lineage Cell Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.